Clinical Trials Logo

Surgical Wound Infection clinical trials

View clinical trials related to Surgical Wound Infection.

Filter by:

NCT ID: NCT00282594 Completed - Sepsis Clinical Trials

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

Start date: July 2003
Phase: N/A
Study type: Interventional

We sought to determine if there is a benefit to using an insulin drip to control hyperglycemia in the surgical critical care unit for patients who undergo general and vascular surgery.

NCT ID: NCT00273377 Completed - Clinical trials for Surgical Wound Infection

The Effects of Hypercapnia, Supplemental Oxygen, and Dexamethasone on Surgical Wound Infection

Start date: May 2002
Phase: Phase 3
Study type: Interventional

The investigators will test the hypotheses that mild hypercapnia and supplemental oxygen reduce wound infection risk in patients undergoing colon resection. The investigators will simultaneously test the hypothesis that low-dose dexamethasone (a common treatment for postoperative nausea and vomiting) does not increase infection risk.

NCT ID: NCT00272675 Completed - Clinical trials for Surgical Site Infection

Prevention of Nosocomial Infection by Decontamination of the Naso- and Oropharynx With Chlorhexidine (NONI Trial)

Start date: August 2003
Phase: Phase 2/Phase 3
Study type: Interventional

Does chlorhexidine gluonate, a simple broad-spectrum antimicrobial agent with virtually no adverse-effects lower the incidence of NI after cardiac surgery, especially with respect to LTI and SSI?

NCT ID: NCT00090272 Completed - Colorectal Surgery Clinical Trials

A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)

Start date: April 2002
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety and efficacy of a one time dose of an intravenous marketed drug being evaluated for a new indication as compared to a marketed drug already approved for the prevention of surgical site infection following colorectal surgery.